UK considers preventative drugs for breast cancer (Update)

January 15, 2013

Britain's National Health Service may soon offer women at high risk of developing breast cancer drugs normally used to treat the disease as a prevention strategy.

The National Institute for Health and Clinical Excellence on Tuesday announced draft guidelines that would make the drugs available.

A final decision is expected this spring after medical groups, charities and patients' organization respond to the proposal.

The proposal suggests that tamoxifen or raloxifene should be used by women found at high risk of developing the disease.

Clinical trials have shown the drugs can be effective in cutting breast cancer rates, and the medications are used both to treat and to prevent the disease in other countries, including the United States.

Initial response from charities and patients groups to the proposal has been favorable.

The charity Breakthrough Breast Cancer called the move "an historic step" in the fight against the deadly disease.

Specialist nurse Jackie Harris with the Breast Cancer Care charity said the proposal could be "very good news" for women with a family history of breast cancer, but doctors cautioned that the drugs cannot be viewed as a vaccine against breast cancer.

Explore further: More heart problems with two chemo drugs for breast cancer

shares

Related Stories

More heart problems with two chemo drugs for breast cancer

August 30, 2012
Women who have breast cancer and are treated with two chemotherapy drugs may experience more cardiac problems like heart failure than shown in previous studies, according to a new Cancer Research Network study by Group Health ...

Decision guide reduced uncertainty over breast cancer prevention, study finds

April 15, 2012
When women at high risk of breast cancer viewed a customized web-based decision guide about prevention options, they were more likely to make a choice about prevention and to feel comfortable with their choice, a new study ...

Toxicity of aromatase inhibitors may explain lack of overall survival improvement

August 22, 2011
The toxicities associated with aromatase inhibitors (AIs) may explain the lack of overall survival improvement compared with tamoxifen, according to a study published August 22 in the Journal of The National Cancer Institute.

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.